EATRIS response to the CoVid19 pandemic


EATRIS mission is to accelerate the translation of promising scientific discoveries into benefits for patients. We focus our main activities on bridging the innovation gap between the lab and the clinic and we offer services and expertise to increase chances of research to successfully reach patients.

The EATRIS infrastructure’s resources are therefore highly relevant for the research community in the context of the COVID-19 pandemic, and include numerous following expertise and services.


CoVid19 : advice for patients with neurodegenerative diseases

Associations are mobilized during the CoVid19 epidemic to help persons with neurodegenerative diseases to face the situation by giving advice for patients and their families.

You can read here the newsletter from Fondation Vaincre Alzheimer, with advice about confinement, hygene measures...

The Michael J Fox Foundation offers a webinar with information about the coronavirus for Parkinson's community.

Stay safe and strong !

Open session on Parkinson's disease

Join us for the open session of the HOPE 2020 congress on Thursday, January 30, 2020 at ICM from 6PM ! An inspiring overview of new surgical techniques for Parkinson patients by Professor Stéphane PALFI, a testimony by a patient-expert, more about brain donation and its usefulness for researchers by professor Charles DUYCKAERTS, ...

HOPE 2020: Submission and registration are open !

The second edition of the "pHysiopathology of Parkinson's DisEase" (HOPE) conference will be held from 29 to 31 January 2020 at ICM in Paris.

Following the success of the first edition and the very stimulating feedback from participants regarding the latest scientific advances and the integration of basic research into clinical research, we are pleased to invite you to take part in this second edition.

The topics will cover the epigenetic and genetic determinants of Parkinson's disease, their molecular mechanisms and their modelling, in order to better understand the pathophysiology of Parkinson's disease and open pre-clinical, clinical and imaging perspectives.

In addition we propose a workshop the first day on two topics that will be discussed later on during the congress

1) Cellular modelling using microfluidic and stem cell technologies

2) Available imaging tools for cellular models and to humans


Submission and registrations are available on the conference website:

Submission deadline: December 1st, 2019

Registration deadline: January 12, 2020

If you would like to contribute to the organization of this event, we are happily welcoming sponsorship: